Testimonials

Details

READING TIME

3 min

CATEGORY

News

AUTHOR

John Dawod

TOPIC

Amyloidosis Africa

Amyloidosis Africa Testimonials

As someone working closely with patients, clinicians, and researchers across Africa, I have witnessed firsthand how delayed diagnosis and limited awareness of amyloidosis affect lives. The stories shared by colleagues, patients, and partners reflect both the challenges we face and the impact that collaboration, education, and timely recognition can make. These testimonials represent real experiences and shared commitment to improving amyloidosis care across Africa.

John Dawod

John Dawod

Founder, Amyloidosis Africa

For too long, patients across Africa have died undiagnosed. Amyloidosis Africa exists to change that through clinician education and regional collaboration.

Rated 5 out of 5

Dr. Constantin Nyamuzangura

BURUNDI CARDIAC SOCIETY PRESIDENT

We are building a continent-wide network of cardiologists committed to improving care for patients with amyloidosis. This collaboration is long overdue, and absolutely necessary.

Rated 5 out of 5

Prof. Yasser Hosny

KENYA CARDIAC SOCIETY PRESIDENT

Recognizing the red flags of amyloidosis early can save lives. We’re empowering frontline healthcare providers with the tools to do just that.

Rated 5 out of 5

Dr. George Otieno

Cardiologist | Lecturer | KCS Board Member

Cardiac amyloidosis remains underrecognized across Africa. Initiatives like Amyloidosis Africa are essential to improve awareness, early diagnosis, and collaboration among African physicians.

Rated 5 out of 5

Dr. Mazou Ngou Temgoua

Cardiologist, Electrophysiology and Inherited Cardiac Diseases, Cameroon

Improving awareness and early recognition of amyloidosis is critical for better patient outcomes. Initiatives that build local capacity and promote collaboration are an important step toward strengthening care across Africa.

Rated 5 out of 5

Dr. Sameh Geress

Cardiologist, zimbabwe

Cardiac amyloidosis is no longer a rare disease; it’s a rarely diagnosed one. Through Amyloidosis Africa, we are reshaping how Africa detects and manages this hidden epidemic.

Rated 5 out of 5

Prof. Leonard Ngunga

KENYA CARDIAC SOCIETY PRESIDENT

Amyloidosis remains underrecognized in many African settings. Initiatives that strengthen awareness, early diagnosis, and clinical capacity are essential to improving outcomes for patients with heart failure and related conditions.

Rated 5 out of 5

Dr. Anders Barasa

HEART FAILURE SPECIALIST

Improving awareness and early recognition of amyloidosis is critical for better patient outcomes. Initiatives that build local capacity and promote collaboration are an important step toward strengthening care across Africa.

Rated 5 out of 5

Dr. Christine Mwachari

The Kenya Medical Research Institute (KEMRI)